Q3 2024 Earnings Call Transcript February 10, 2025 Roivant Sciences Ltd. beats earnings expectations. Reported EPS is $0.23, expectations were $-0.24. Operator: Ladies and gentlemen, thank you for ...

Stephanie Lee Griffin; Chief Operating Officer; Roivant Sciences Ltd. Matt Gline; Chief Executive Officer, Director; Roivant Sciences Ltd. Dave Risinger; Analyst; Le ...

The Nasdaq is one of the top three most-followed stock market indices in the United States, comprising over 2,500 stocks.

Roivant Sciences Ltd (ROIV) showcases strong financials and strategic advancements while navigating ongoing litigation and competitive pressures.

NIH grant recipients receive additional funding to cover "indirect costs," such as building maintenance and administrative ...

Disinformation campaigns targeting the Quad, a partnership between Australia, India, Japan, and the United States, challenge ...

The pandemic death total stands at 1,252 as of February 1, 2025 (the most recent data available). The 5 reported deaths last ...

SINGAPORE: The Ministry of Health (MOH) announced on Monday (Feb 10) that it will extend subsidies and MediSave usage for ...

Pfizer Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Scrap for the year ending 31-Mar-2024.For the quarter ended 31-12-2024, the company has reported a Standalone Total ...